American Skin Association Unveils 2025 Research Grant Winners
The American Skin Association (ASA) is thrilled to announce its annual research grant recipients, supporting groundbreaking work aimed at combating skin diseases and cancer. This year, fifteen diligent researchers have been selected from a competitive field, joining a community of over 300 innovators dedicated to advancing skin health.
Highlighting This Year’s Remarkable Grant Recipients
Among the distinguished awardees are four Investigative Scientist Award recipients, showcasing the breadth of talent in dermatological research. Patrick Brunner, MD, MSc, from the Icahn School of Medicine at Mount Sinai, has been recognized with the Calder Investigative Award for his pioneering work in vitiligo.
Similarly, Anna Eisenstein, MD, PhD, from Yale University, received the Sanofi Regeneron Investigative Scientist Award for her research in atopic dermatitis. Nicholas Gulati, MD, PhD, from the same institution, was honored with a Sun Pharma Investigative Scientist Award, alongside Jinwoo Lee, MD, PhD, from Stanford University, highlighting the excellence in this year’s submissions.
Driving Research in Psoriasis and Other Skin Conditions
The Johnson & Johnson Research Scholar Award went to Christine Yokoyama, MD, PhD, from Washington University, recognizing her contributions to psoriasis research. Additionally, ASA awarded two research grants and seven grants to medical students, indicating a robust investment in the future of dermatological research.
This year’s pivotal grants have been made possible due to the generous support from a community of individuals, foundations, and corporations who believe in advancing skin health, particularly among vulnerable populations such as children. ASA’s mission to educate the public regarding skin diseases underscores its commitment to fostering a healthier community.
The Legacy of ASA’s Grant Program
Over the past thirty-eight years, ASA has invested over $50 million in research grants, benefiting more than 100 million Americans suffering from skin disorders. ASA's ongoing commitment is to enhance therapeutic options and to push forward towards cures for various skin conditions including melanoma and psoriasis.
"The annual grant program is critical to furthering dermatological research and aid ASA’s mission of eradicating skin cancers like melanoma," stated ASA Chairman Howard P. Milstein. This research is crucial for discovering new treatments, offering hope to millions impacted by skin diseases.
Support and Oversight by Experts
The robust grant program is overseen by ASA’s Medical Advisory Committee (MAC), composed of an elite group of scientists and physicians who dedicate their expertise to guide the annual process. Their leadership ensures that ASA supports the full spectrum of researchers, from emerging talents to established figures in dermatology.
"We're excited to present the 2025 awards to such deserving researchers," remarked ASA President and MAC Co-Chair Dr. James G. Krueger. The committee's commitment reinforces their goal of funding valuable research that contributes to long-awaited solutions for diseases like vitiligo, melanoma, and several others.
Embarking on Innovative Research Projects
ASA’s financial contributions allow both established researchers and medical students to delve into significant issues surrounding melanoma and non-melanoma skin cancers. These grants have played a crucial role in cultivating the careers of many promising investigators and have significantly impacted dermatology research and clinical practices.
The 2025 awardees will tackle a variety of projects aimed at unraveling the complexities of skin diseases further:
Patrick Brunner will examine tape-strip profiling in vitiligo, while Anna Eisenstein's project will study the implications of skin inflammation in atopic dermatitis on allergic immune responses. Jinwoo Lee aims to assess the role of RNA-protein particles in autoimmune diseases, whereas Nicholas Gulati will explore mechanisms behind vitiligo lesions.
Continuing the Fight Against Skin Diseases
The ASA’s dedication to combating skin disorders shines through every new project funded. The recent medical student grants also emphasize elevating young talent passionate about dermatological research, bolstering the next generation's drive to advance skin health.
As a leading organization involved in skincare advocacy, ASA fosters collaborations among patients, families, doctors, and scientists to guide meaningful initiatives. The organization's efforts are critical to understanding, preventing, and treating skin disorders affecting so many lives in the United States.
About the American Skin Association
Established as a non-profit organization, the American Skin Association aims to serve a growing population afflicted with skin disorders. Their mission revolves around advancing research, improving skin health among children, and raising public awareness regarding skin diseases. ASA proudly holds Candid's 2025 Seal of Platinum Transparency and boasts a Four-Star Rating from Charity Navigator for its commitment to transparency and impact.
Frequently Asked Questions
What is the American Skin Association?
The American Skin Association is a non-profit organization dedicated to advancing skin health and research, focusing on conditions like melanoma, vitiligo, and psoriasis.
How many researchers received grants in 2025?
Fifteen researchers received grants from the American Skin Association in 2025 to support their innovative projects.
Who are notable recipients of this year's grants?
Some prominent recipients include Patrick Brunner, Anna Eisenstein, and Christine Yokoyama, recognized for their impactful research projects.
What is the funding history of the American Skin Association?
Over the past thirty-eight years, ASA has provided over $50 million in funding for dermatology research, helping to advance the understanding and treatment of skin diseases.
How can the public get involved with ASA?
The public can support ASA's mission by participating in events, donating, or raising awareness about skin health issues in their communities.
